Novel Biomarkers of Diabetic Kidney Disease-Reference-Cited by-同舟云学术

Novel Biomarkers of Diabetic Kidney Disease

Published:2023-03-31 Issue:4 Volume:13 Page:633
ISSN:2218-273X
Container-title:Biomolecules
language:en
Short-container-title:Biomolecules

Author:

Rico-Fontalvo Jorge¹²^ORCID,Aroca-Martínez Gustavo¹²,Daza-Arnedo Rodrigo¹,Cabrales José³^ORCID,Rodríguez-Yanez Tomás⁴^ORCID,Cardona-Blanco María¹,Montejo-Hernández Juan¹,Rodelo Barrios Dairo⁵^ORCID,Patiño-Patiño Jhonny⁶,Osorio Rodríguez Elber⁷^ORCID

Affiliation:

1. Nephrologist, Colombian Association of Nephrology, Bogota 110221, Colombia

2. Faculty of Medicine, Universidad Simón Bolívar, Barranquilla 080002, Colombia

3. Nephrology Fellow, Stanford University School of Medicine, Palo Alto, CA 94305, USA

4. Internal Medicine, Universidad de Cartagena, Cartagena 130001, Colombia

5. Graduate Student in Critical Medicine and Intensive Care, Simon Bolivar University, Barranquilla 080002, Colombia

6. Independent Researcher, Barranquilla 080002, Colombia

7. Group of Intensive Care and Comprehensive Care (GRIMICI), Barranquilla 080002, Colombia

Abstract

Diabetic kidney disease (DKD) is a highly prevalent condition worldwide. It represents one of the most common complications arising from diabetes mellitus (DM) and is the leading cause of end-stage kidney disease (ESKD). Its development involves three fundamental components: the hemodynamic, metabolic, and inflammatory axes. Clinically, persistent albuminuria in association with a progressive decline in glomerular filtration rate (GFR) defines this disease. However, as these alterations are not specific to DKD, there is a need to discuss novel biomarkers arising from its pathogenesis which may aid in the diagnosis, follow-up, therapeutic response, and prognosis of the disease.

Publisher

MDPI AG

Subject

Molecular Biology,Biochemistry

Link

https://www.mdpi.com/2218-273X/13/4/633/pdf

Reference77 articles.

1. Rico-Fontalvo, J., Aroca, G., Cabrales, J., Daza-Arnedo, R., Yánez-Rodríguez, T., Martínez-Ávila, M.C., Uparella-Gulfo, I., and Raad-Sarabia, M. (2022). Molecular mechanisms of diabetic kidney disease. Int. J. Mol. Sci., 23.

2. Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease;Jung;Diabetes Metab. J.,2022

3. Inflammation and diabetic kidney disease: New perspectives;Jorge;J. Biomed. Res. Environ. Sci.,2022

4. Diabetic kidney disease: Updating;Raad;Rev. Andal. Fac. Med.,2022

5. Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease;Mischak;Diabetologia,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers and signaling pathways of diabetic nephropathy and peripheral neuropathy: possible therapeutic intervention of rutin and quercetin;Diabetology International;2023-12-19

2. Systemic biomarkers of microvascular alterations in type 1 diabetes associated neuropathy and nephropathy - A prospective long-term follow-up study;Journal of Diabetes and its Complications;2023-12

3. Proteonano™: a novel deep proteomics platform with 1000-plex profiling capacity and picogram sensitivity and its application in diabetic kidney disease;2023-09-14

4. Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies;International Journal of Molecular Sciences;2023-08-03

5. Identifying Biomarkers for Diabetic Kidney Disease Using GraphSAGE Neural Network;Journal of Computer and Communications;2023